Caribou Biosciences, Inc. (CRBU) has 13 open-market insider trades by 7 insiders since 2021. The most active filer is Ryan Fischesser, VP & Controller.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Steven Kanner | CSO | — | 2 | $886K | 2025-02-21 |
| Ryan Fischesser | VPController | — | 4 | $145K | 2024-11-20 |
| Barbara G. McClung | CLO | — | 2 | $41K | 2026-02-24 |
| Syed Ali-aamir Rizvi | Chief Medical Officer | — | 1 | $36K | 2023-01-19 |
| Sriram Ryali | CFO | — | 1 | $25K | 2026-02-20 |
| Rachel E. Haurwitz | Pres | — | 1 | $20K | 2026-02-20 |
| Timothy P. Kelly | CTO | — | 2 | $18K | 2026-02-25 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Timothy P. Kelly | CTO | Sell | $12K | 2026-02-25 |
| Barbara G. McClung | CLO | Sell | $14K | 2026-02-24 |
| Tina M. Albertson | Chief Medical Officer | Sell | $2K | 2026-02-24 |
| Timothy P. Kelly | CTO | Sell | $6K | 2026-02-24 |
| Rachel E. Haurwitz | President | Buy | $20K | 2025-03-14 |
| Ruhi Ahmad Khan | Chief Business Officer | Sell | $5K |
Companies that share insiders with CRBU, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2025-02-21 |
| Sriram Ryali | CFO | Buy | $25K | 2025-01-29 |
| Syed Ali-aamir Rizvi | Chief Medical Officer | Sell | $36K | 2023-01-19 |
| Ryan Fischesser | VP & Controller | Sell | $108K | 2022-10-06 |
| Steven Kanner | CSO | Sell | $970K | 2022-08-25 |
| Ryan Fischesser | Controller | Buy | $30K | 2022-01-11 |
| Ryan Fischesser | Controller | Buy | $3K | 2021-12-20 |
| Barbara G. McClung | CLO | Buy | $16K | 2021-12-07 |
| Barbara G. McClung | CLO | Buy | $25K | 2021-10-20 |
| Steven Kanner | CSO | Buy | $401K | 2021-10-12 |